Latest Amyloid precursor protein secretase Stories
Scientists from VIB and KU Leuven have discovered a new target molecule for the development of a treatment against Alzheimer's disease.
Scientists recently announced that they had discovered a gene that fights Alzheimer’s. This is a positive step forward as the gene could help develop treatments to fight the disorder.
Researchers at the University of California, San Diego, the Medical University of South Carolina, the University of Cincinnati, and American Life Science Pharmaceuticals of San Diego have validated the protease cathepsin B (CatB) as a target for improving memory deficits and reducing the pathology of Alzheimer's disease (AD) in an animal model representative of most AD patients.
Sluggish recycling of a protein-slicing enzyme could promote Alzheimer's disease.
Nutri-Med Logic Corp discusses the role of R-Alpha Lipoic and Omega-3 as a vehicle to improve the homeostasis. It has been suggested that redox imbalance causes alteration in the production of the protein Amyloid Beta pathways (gamma vs.
CAMBRIDGE, Mass., July 18, 2011 /PRNewswire/ -- Satori(TM) Pharmaceuticals today announced the presentation of two posters at the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) taking place in Paris, France, July 16-21, 2011.
Researchers pinpoint a small RNA that spurs cells to manufacture a particular splice variant of a key neuronal protein, potentially promoting Alzheimer's disease (AD) or other types of neurodegeneration.
Researchers pinpoint a small RNA that triggers cells to manufacture a particular splice variant of a key neuronal protein, potentially promoting Alzheimer's disease (AD) or other types of neurodegeneration.